Inducing regeneration

-
In many ways, regeneration is the ‘holy grail’ of medical research. To be able to completely heal from injuries and to regrow lost organs or tissues is a feat that most mammals are generally not capable of. However, many types of animals can regenerate to varying degrees, and some mammalian tissues do normally display regenerative capabilities. Studying model organisms has provided some insight into the biochemical pathways that allow regeneration in certain systems, as well as mechanisms that prevent regeneration in others. Here are a couple of recent studies which could represent major breakthroughs in regeneration research.

Epigenetic barriers prevent regeneration in the eye  

In adult mammals, the retina is almost completely incapable of regeneration. In contrast, bony fish can regenerate retinal tissue lost due to injury. The process of retinal regeneration in fish requires the generation of new neurons from Müller glial cells within the eye, driven by the activity of the proneural transcription factor Ascl1.  Based on this, researchers discovered that expression of an Ascl1 transgene in mouse Müller glia induces neurogenesis and facilitates retinal regeneration in young mice. But, disappointingly, this regenerative ability is lost in mice older than 16 days (1). Jorstad et al. have now shown that a chromatin state change is the cause of the inability of Ascl1 to facilitate retinal regeneration in adult mice (2) In a recent Nature paper, they demonstrate that treatment with a histone deacetylase inhibitor along with forced expression of Ascl1 in Müller glia enables adult mice to regenerate retinal tissue after an injury. This finding may have profound implications for treating human retinal damage.

Identifying the directors of myelin regeneration

In healthy mammalian brains, the myelin sheaths surrounding neurons can regenerate after injury and inflammation. This process involves new oligodendrocytes differentiating from progenitor cells in the damaged tissue. However, in people with multiple sclerosis (MS), myelin regeneration often fails due to a reduction in oligodendrocyte differentiation. In a new paper, Dombrowski et al. show that regulatory T cells (Treg), a specialized T cell subset, promote remyelination by stimulating oligodendrocyte differentiation (3). Using a transgenic model for Treg ablation, they showed that without Tregs, remyelination is severely impaired, like some MS models. They also identified CCN3 as a Treg -secreted factor which mediates oligodendrocyte differentiation. This study potentially provides groundwork for future treatments of demyelinating diseases such as MS, and also contributes to a growing understand of Treg functions in cell differentiation and tissue repair (4-7).

References

  1. Ueki Y, et al. Transgenic expression of the proneural transcription factor Ascl1 in Müller glia stimulates retinal regeneration in young mice. Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13717-22.
  2. Jorstad NL, et al. Stimulation of functional neuronal regeneration from Müller glia in adult mice. Nature. 2017 Aug 3;548(7665):103-107.
  3. Dombrowski Y, et al. Regulatory T cells promote myelin regeneration in the central nervous system. Nat Neurosci. 2017 May;20(5):674-680.
  4. Ali N, et al. Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation. Cell. 2017 Jun 1;169(6):1119-1129.e11.
  5. Weirather J, et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res. 2014 Jun 20;115(1):55-67.
  6. Arpaia N, et al. A Distinct Function of Regulatory T Cells in Tissue Protection. Cell. 2015 Aug 27;162(5):1078-89.
  7. Burzyn D, et al. A special population of regulatory T cells potentiates muscle repair. Cell. 2013 Dec 5;155(6):1282-95.
Original Source: Cyagen Biosciences

Comments

Post a Comment

Popular posts from this blog

Knockout by CRISPR vs Knockdown by shRNA

-
In solving the mystery of gene function, there is no more important clue than the phenotype of inactivating the gene of interest. With a plethora of methods available, researchers must first determine what approach is best for their specific scientific questions and experimental systems. For over a decade, RNA-interference-based methods of gene knockdown (i.e. RNAi & shRNA) have provided a wealth of insight into gene function, but in recent years the advent of CRISPR- and TALEN-based methods now allow genome editing to be used to quickly and efficiently test the effect of gene knockouts. Here, we review the advantages and disadvantages of these approaches, and describe some experimental situations in which one approach is better than another, focusing primarily on CRISPR/Cas9 and shRNA. For a discussion of the relative advantages of CRISPR/Cas9 versus TALEN , see our prior Newsletter on this topic. CRISPR Knockout In this method, a guide RNA (gRNA) homologous to an 18-22nt ta
Read more

Extending Lifespan of Mice, Then Human

-
Image
Invariably, everyone gets old. However, as a true testament to human stubbornness, research toward a “cure” for aging has never stopped. Over the past few decades, various approaches have allowed scientists to generate animal models with extended lifespans. In recent years, this trend has moved from lower organisms to mammalian model systems. There are now several rodent models with enhanced longevity. Many of these models are directly relevant to human aging. A new study has identified a deletion in exon 3 of human growth hormone receptor (GHR) to be prevalent in naturally long-lived men (1). The presence of two copies of this mutation may allow men to live about ten years longer than they otherwise would. This agrees with many findings from rodent models. Transgenic mice that overexpress GH age rapidly, while knockout mice lacking GHR are long-lived (2,3). In humans and mice, IGF1 signaling is also closely linked to longevity via a signaling pathway overlapping that of GH (4,5).
Read more

Healing a broken heart

-
Image
Introduction: Reduced heart function due to aging and disease is a major health problem. Heart attacks can have devastating impacts, often leading to the death of the patient or chronic morbidity for those that survive. A major reason for the sensitivity of the circulatory system to heart malfunction is that heart muscle cells (cardiomyocytes) of adult mammals generally do not divide. This means that when a cardiomyocyte dies, due to localized loss of blood supply, for example, that dead cell will never be replaced. Normally, heart tissue has a robust, healthy blood supply, but when a heart attack strikes, portions of heart tissue are deprived of blood flow, resulting in rapid cell death in those sections of the heart. Recovering the ability to heal Interestingly, newborn hearts can heal. In 2011, scientists discovered that newborn mice are able to regenerate cardiomyocytes to repair heart damage, but this ability is lost soon after birth (1). More recently, researchers disc
Read more